相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy
Patricia P. Bloom et al.
ANNALS OF HEPATOLOGY (2021)
Nitazoxanide versus rifaximin in preventing the recurrence of hepatic encephalopathy: A randomized double-blind controlled trial
Khadija A. M. Glal et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2021)
Fecal microbiota transplantation in hepatic encephalopathy: a systematic review
Mathias Madsen et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Neuroinflammation in Murine Cirrhosis Is Dependent on the Gut Microbiome and Is Attenuated by Fecal Transplant
Runping Liu et al.
HEPATOLOGY (2020)
Comparative Efficacy of Treatment Options for Minimal Hepatic Encephalopathy: A Systematic Review and Network Meta-Analysis
Radha K. Dhiman et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Probiotics: Promise, Evidence, and Hope
Alexander Khoruts et al.
GASTROENTEROLOGY (2020)
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Christopher F. Rose et al.
JOURNAL OF HEPATOLOGY (2020)
Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis
Jasmohan S. Bajaj et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo-Controlled Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2019)
Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial
Ji Yao Wang et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy
Alba Mangas-Losada et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials
Takumi Kawaguchi et al.
HEPATOLOGY RESEARCH (2019)
Bile Acids in Hepatic Encephalopathy
Sharon DeMorrow
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2019)
Predicting Clinical Outcomes of Cirrhosis Patients With Hepatic Encephalopathy From Fecal Microbiome
Chang Mu Sung et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)
Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis
Qing Cao et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)
Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity
H. Takaya et al.
JOURNAL OF HEPATOLOGY (2018)
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis
Xiaoxue Xia et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2018)
Combining amplicon sequencing and metabolomics in cirrhotic patients highlights distinctive microbiota features involved in bacterial translocation, systemic inflammation and hepatic encephalopathy
Valerio Iebba et al.
SCIENTIFIC REPORTS (2018)
Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease
C. A. Woodhouse et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Fecal Microbiota Transplantation
Stephen M. Vindigni et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)
Gut Microbiota and Complications of Liver Disease
Chathur Acharya et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)
Fecal Microbiota Transplant From a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial
Jasmohan S. Bajaj et al.
HEPATOLOGY (2017)
Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction
Wei-Wei Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Effect of different treatments and alcohol addiction on gut microbiota in minimal hepatic encephalopathy patients
Zan Zuo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Probiotics for people with hepatic encephalopathy
Rohan Dalal et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Introduction: understanding mechanisms of the actions of rifaximin in selected gastrointestinal diseases
H. L. DuPont
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis
J. S. Bajaj
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)
Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study
Sanath Allampati et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Fecal microbiota transplantation in the management of hepatic encephalopathy
Dina Kao et al.
HEPATOLOGY (2016)
Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure
Matthew McMillin et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy
Nicolas Weiss et al.
JOURNAL OF HEPATOLOGY (2016)
Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis
Vishwadeep Ahluwalia et al.
SCIENTIFIC REPORTS (2016)
Rifaximin Exerts Beneficial Effects Independent of its Ability to Alter Microbiota Composition
Dae J. Kang et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2016)
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Jasmohan S. Bajaj et al.
HEPATOLOGY (2015)
Engineering the gut rnicrobiota to treat hyperammonemia
Ting-Chin David Shen et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial
Venigalla Pratap Mouli et al.
HEPATOLOGY RESEARCH (2015)
Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus
Jasmohan S. Bajaj et al.
SCIENTIFIC REPORTS (2015)
Hepatic Encephalopathy: Historical Remarks
Piero Amodio
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2015)
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis
J. S. Bajaj et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial
Manish Kumar Lunia et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Probiotic VSL#3 Reduces Liver Disease Severity and Hospitalization in Patients With Cirrhosis: A Randomized, Controlled Trial
Radha K. Dhiman et al.
GASTROENTEROLOGY (2014)
Hepatic Encephalopathy in Chronic Liver Disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver
Hendrik Vilstrup et al.
HEPATOLOGY (2014)
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)
Juan Cordoba et al.
JOURNAL OF HEPATOLOGY (2014)
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Jasmohan S. Bajaj et al.
JOURNAL OF HEPATOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
Large-Scale Survey of Gut Microbiota Associated With MHE Via 16S rRNA-Based Pyrosequencing
Zhigang Zhang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Genta Kakiyama et al.
JOURNAL OF HEPATOLOGY (2013)
Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
Jasmohan S. Bajaj et al.
PLOS ONE (2013)
Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Linkage of gut microbiome with cognition in hepatic encephalopathy
Jasmohan S. Bajaj et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Human gut microbiome viewed across age and geography
Tanya Yatsunenko et al.
NATURE (2012)
Techniques used to characterize the gut microbiota: a guide for the clinician
Marianne H. Fraher et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Bile acids content in brain of common duct ligated rats
Valeria Tripodi et al.
ANNALS OF HEPATOLOGY (2012)
Characterization of Fecal Microbial Communities in Patients with Liver Cirrhosis
Yanfei Chen et al.
HEPATOLOGY (2011)
Infection and systemic inflammation, not ammonia, are associated with Grade 3/4 hepatic encephalopathy, but not mortality in cirrhosis
D. L. Shawcross et al.
JOURNAL OF HEPATOLOGY (2011)
Pathogenesis, Diagnosis, and Treatment of Hepatic Encephalopathy
Dileep K. Atluri et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2011)
Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy
Mariano Malaguarnera et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Role of ammonia and inflammation in minimal hepatic encephalopathy
D. L. Shawcross et al.
METABOLIC BRAIN DISEASE (2007)
Brain metabolism of N-13-ammonia during acute hepatic encephalopathy in cirrhosis measured by positron emission tomography
S Keiding et al.
HEPATOLOGY (2006)
Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis
DL Shawcross et al.
JOURNAL OF HEPATOLOGY (2004)
Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis
Q Liu et al.
HEPATOLOGY (2004)
Probiotics can treat hepatic encephalopathy
SF Solga
MEDICAL HYPOTHESES (2003)
Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
P Ferenci et al.
HEPATOLOGY (2002)
分享论文
